Home > Latha Jishnu
‘Lethal’ changes
31 Oct 2023 6:20 PM ISTThe proposed amendments to India’s patent laws are a capitulation to Big Pharma and will undermine vital public health safeguards in the law
Pair of perils
24 Oct 2023 5:32 PM ISTWhile a few generic giants, including one from Israel, are found guilty of fuelling fatal opioid crisis in the US, the US-backed “genocide” targeting...
Turning back the pages
11 April 2023 6:47 PM ISTThe 2013 landmark Supreme Court judgement of 'Novartis v Union of India' offers critical lessons on the intent behind crucial aspects of India’s key...
Spurious endeavour
6 April 2023 6:39 PM ISTThe move to foist a GI tag on Mandu’s baobab tree is part of a drive to push up the GI tally which does not benefit local communities
Trade lessons from 'Cuetlaxochitl'
24 Dec 2022 8:49 PM ISTThe story of poinsettia, a flower with showy-red bracts used for Christmas decorations in America since the 16th century, is a classic example of...
Where do we stand?
13 Oct 2022 4:03 PM ISTPolicy blocks and poor vision have held up 5G in India, while China’s breakthroughs are helping to set global standards
A lethal lapse
29 Sept 2022 9:28 PM ISTCancer and tuberculosis patients have been urging a reluctant government to use compulsory licences to make life-saving drugs accessible
Battle for prestige
15 Sept 2022 7:45 PM ISTModerna is trying to be gatekeeper for the mRNA platform for future drug development — raising monopolistic fears
Repeat of a failure?
25 Aug 2022 11:30 PM ISTA pattern familiar to Covid-19 is emerging in the battle against monkeypox, with the US and Europe grabbing scarce vaccine supplies
Done with vaccines?
28 July 2022 8:43 PM ISTIndia claims vaccines are no longer an issue in the battle against COVID-19, but a host of developing nations would disagree
A tool of war?
27 July 2022 7:24 PM ISTPost the Ukraine war, Russia has held back from appropriating intellectual property despite having a law to punish unfriendly countries
Charity after profiteering!
19 Jun 2022 12:47 AM ISTAfter facing a worldwide censure for earning disproportionately during the pandemic, pharma giant Pfizer has decided to supply its patented,...